Dr Othmar G Engelhardt
Principal Scientist in the Division of Virology at the National Institute for Biological Standards and Control, a centre of the Medicines and Healthcare products Regulatory Agency, UK.
Othmar G Engelhardt received a doctorate degree from the University of Natural Resources and Applied Life Sciences, Vienna, Austria. Working at the Mount Sinai School of Medicine, New York, USA, the University of Freiburg, Germany, and the University of Oxford, UK, he has been involved in research into various aspects of influenza virus and other negative strand RNA viruses.
Current research interests include the improvement of growth and yield of candidate influenza vaccine viruses, the development and assessment of new assays for the standardisation of influenza vaccines, the standardisation of serological assays for influenza virus, the use of in vivo models in vaccine evaluation and the standardisation of RSV serology.
He is involved in various WHO projects; including seasonal and pandemic influenza strain selection. Othmar has served as temporary adviser to WHO, and as technical expert at the European Medicines Agency and the UK Department of Health.
Dr Katja Hoschler
Advanced Clinical Scientist at the Respiratory Virus Unit, Virus Reference Department, Public Health, Colindale, England
Katja Hoschler is responsible for development, application and expansion of serological/biological research in the Respiratory Virus Unit with special emphasis on detection/confirmation of infection and identification of immunological correlates of protection from avian and other unusual influenza viruses.
Since 2008 she has been an advanced Clinical Scientist, prior to which Katja was Research Scientist at Solexa Ltd (now ILLUMINA Ltd), UK. From 1999 – 2002 she was Research Scientist & Project Leader, Labor Diagnostik GmbH, Leipzig (now QIAGEN Leipzig GmbH) Germany